# Microglial Activation Role In ALS (MARIA)

> **NCT02405403** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University Hospital, Tours**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** [18F]DPA-714 PET

## Key facts

- **NCT ID:** NCT02405403
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2016-09
- **Final completion:** 2017-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** It was more difficult than planned to find patients filling inclusion criteria and those which corresponded didn't agree to participate
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02405403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02405403, "Microglial Activation Role In ALS (MARIA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02405403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*